Physician

Patti K.m. Endo, M.D.

According to 2025 Medicare claims, Patti Endo, M.D. (NPI: 1699870956) practices dermatology in the Kahului-Wailuku, HI market, with the plurality of this provider's patient population coming from Maui, HI. This provider's primary affiliated billing organization is PATTI K M ENDO MD INC (NPI: 1972893980) and primary practice location at 96793-2365.

Endo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 776 traditional Medicare patients, billed 5,226 HCPCS/CPT codes, and received $206,810 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 846 prescription claims across 324 beneficiaries totaling $162,510 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 16 records totaling $419. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$113K$225K2015 Medicare payment: $201,306 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $201,090 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $195,109 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $188,029 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $225,382 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $190,496 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $210,216 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $212,502 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $219,568 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $206,810 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157794,856$201,306
20168095,217$201,090
20178145,057$195,109
20187924,971$188,029
20198515,745$225,382
20206954,675$190,496
20217124,799$210,216
20227595,195$212,502
20238015,279$219,568
20247765,226$206,810

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$84K$169K2015 Drug cost: $157,499 (USD; Tot_Drug_Cst)2016 Drug cost: $146,827 (USD; Tot_Drug_Cst)2017 Drug cost: $168,631 (USD; Tot_Drug_Cst)2018 Drug cost: $132,741 (USD; Tot_Drug_Cst)2019 Drug cost: $155,798 (USD; Tot_Drug_Cst)2020 Drug cost: $127,710 (USD; Tot_Drug_Cst)2021 Drug cost: $109,227 (USD; Tot_Drug_Cst)2022 Drug cost: $122,620 (USD; Tot_Drug_Cst)2023 Drug cost: $113,004 (USD; Tot_Drug_Cst)2024 Drug cost: $162,510 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015353887$157,499
2016346907$146,827
2017404979$168,631
2018373901$132,741
20194541,097$155,798
20204071,055$127,710
2021371998$109,227
2022357942$122,620
2023331904$113,004
2024324846$162,510

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth174204$68
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more6861,151$60
17000Destruction of precancer skin growth, 1 growth459787$42
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more123156$41
17003Destruction of precancer skin growth, 2-14 growths3642,155$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab22784$104,166
AcitretinAcitretin391,527$11,309
TacrolimusTacrolimus25720$8,590
ImiquimodImiquimod1088,232$2,615
Betamethasone DipropionateBetamethasone Dipropionate671,517$2,228

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$419ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Patti K.m. Endo, M.D.?

Tedicare shows public-source Medicare data for Patti K.m. Endo, M.D. (NPI 1699870956), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Patti K.m. Endo, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Patti K.m. Endo, M.D.?

Patti K.m. Endo, M.D. is linked to PATTI K M ENDO MD INC (billing NPI 1972893980) in the available physician profile data.

Does Patti K.m. Endo, M.D. have Open Payments data?

Patti K.m. Endo, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.